Literature DB >> 18395897

Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma.

Yong-Quan Chu1, Zai-Yuan Ye, Hou-Quan Tao, Yuan-Yu Wang, Zhong-Sheng Zhao.   

Abstract

AIM: To evaluate the relationship between the expression of cell adhesion molecules (CAMs) and the biological behavior of gastric carcinoma.
METHODS: Expression of syndecan-1, E-cadherin and integrin beta3 were evaluated by immunohistochemical study in a total of 118 gastric carcinomas and 20 non-tumor gastric mucosas.
RESULTS: The expressions of syndecan-1 and E-cadherin were significantly lower in gastric carcinoma compared to non-tumor gastric mucosa, and the low expression rates were positively correlated to the tumor invasion depth, vessel invasion, lymph node metastasis and distant metastasis (P < 0.01 in all cases). However, the expression of integrin beta3 was significantly higher in gastric carcinoma compared to non-tumor gastric mucosa, and the high expression rates were positively correlated to the tumor invasion depth, vessel invasion, lymph node metastasis and distant metastasis (P < 0.01 in all cases). In addition, the three protein expressions were correlated to the tumor growth pattern (P < 0.01, P < 0.01, and P < 0.05 respectively), but not correlated to tumor differentiation (P > 0.05, P > 0.05 and P > 0.05 respectively). Positive correlation was observed between the expressions of syndecan-1 and E-cadherin, but they which were negatively correlated to the expression of integrin beta3 (P < 0.01 in all cases). Univariate analysis demonstrated that the mean survival time and 5-year survival rate were lower in the cases with low expressions of syndecan-1 and E-cadherin and high expression of integrin beta3 (P < 0.01, in all cases). COX multivariate analysis showed that the expression level of syndecan-1 could be an independent prognostic index of gastric carcinoma (P < 0.01), whereas E-cadherin and integrin beta3 could not be independent indexes (P > 0.05, P > 0.05 respectively).
CONCLUSION: The low expression of syndecan-1 and E-cadherin and the high expression of integrin beta3 are significantly correlated with the invasion and metastasis of gastric carcinoma, and they are highly correlated with each other. Therefore they may serve as important prognostic markers of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395897      PMCID: PMC2701518          DOI: 10.3748/wjg.14.1990

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

Review 1.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Re-study of gastric cancer: analysis of outcome.

Authors:  Prudencio S Samson; Laurence Anthony P Escovidal; Samuel G Yrastorza; Ronaldo G Veneracion; Mary Yvonnette C Nerves
Journal:  World J Surg       Date:  2002-02-04       Impact factor: 3.352

3.  Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.

Authors:  Hideo Kurokawa; Min Zhang; Shinobu Matsumoto; Yoshihiro Yamashita; Toshiko Tanaka; Koichi Takamori; Kaori Igawa; Maho Yoshida; Hiroshi Fukuyama; Tetsu Takahashi; Sumio Sakoda
Journal:  J Oral Pathol Med       Date:  2006-05       Impact factor: 4.253

4.  E-cadherin loss promotes the initiation of squamous cell carcinoma invasion through modulation of integrin-mediated adhesion.

Authors:  Weitian Zhang; Addy Alt-Holland; Alexander Margulis; Yulia Shamis; Norbert E Fusenig; Ulrich Rodeck; Jonathan A Garlick
Journal:  J Cell Sci       Date:  2006-01-03       Impact factor: 5.285

Review 5.  Global cancer statistics in the year 2000.

Authors:  D M Parkin
Journal:  Lancet Oncol       Date:  2001-09       Impact factor: 41.316

6.  Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer.

Authors:  J P Wiksten; J Lundin; S Nordling; M Lundin; A Kokkola; K von Boguslawski; C Haglund
Journal:  Int J Cancer       Date:  2001-01-20       Impact factor: 7.396

7.  Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments.

Authors:  P Zimmermann; D Tomatis; M Rosas; J Grootjans; I Leenaerts; G Degeest; G Reekmans; C Coomans; G David
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

8.  DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma.

Authors:  Jing-Fang Zhang; Yuan-Ping Zhang; Feng-Yun Hao; Cai-Xin Zhang; Yu-Jun Li; Xiang-Rui Ji
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

9.  Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas.

Authors:  Yao-Chi Liu; Chen-Yang Shen; Hurng-Sheng Wu; Tsai-Yuan Hsieh; De-Chuan Chan; Cheng-Jueng Chen; Jyh-Cherng Yu; Cheng-Ping Yu; Horng-Jyh Harn; Peng-Jen Chen; Chung-Bao Hsieh; Teng-Wei Chen; Huan-Mieng Hsu
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

10.  Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer.

Authors:  M Fujiya; J Watari; T Ashida; M Honda; H Tanabe; T Fujiki; Y Saitoh; Y Kohgo
Journal:  Jpn J Cancer Res       Date:  2001-10
View more
  11 in total

1.  Comparison of the Expression of Cell Adhesion Molecule Markers (E-Cadherin and Syndecan-1) between Young and Older Age Patients with Gastric Carcinoma.

Authors:  Bita Geramizadeh; Omid-Ali Adeli; Marjan Rahsaz; Maral Mokhtari; Salma Sefidbakht
Journal:  J Gastrointest Cancer       Date:  2010-09

Review 2.  Syndecans in chronic inflammatory and autoimmune diseases: Pathological insights and therapeutic opportunities.

Authors:  Solomon A Agere; Eugene Y Kim; Nahid Akhtar; Salahuddin Ahmed
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

3.  Association of CDH1 -160 C → A and -347 G→ GA polymorphisms and expression of E-cadherin and gastric cancer: A case-control study.

Authors:  Adem Akçakaya; Nurcan Ünver; Tuğba Aydoğan Kiriş; Mehmet Güzel; Fatma Betül Akçakaya; Bedia Çakmakoğlu; Mustafa Hasbahçeci
Journal:  Turk J Surg       Date:  2021-03-22

4.  Diagnostic model of saliva protein finger print analysis of patients with gastric cancer.

Authors:  Zheng-Zhi Wu; Ji-Guo Wang; Xiao-Li Zhang
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

5.  Caveolin-1, E-cadherin and β-catenin in Gastric Carcinoma, Precancerous Tissues and Chronic Non-atrophic Gastritis.

Authors:  Guo-Yang Sun; Jun-Xia Wu; Jian-Sheng Wu; Yu-Ting Pan; Rong Jin
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

Review 6.  Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication.

Authors:  Tünde Szatmári; Rita Ötvös; Anders Hjerpe; Katalin Dobra
Journal:  Dis Markers       Date:  2015-09-01       Impact factor: 3.434

Review 7.  Syndecans as Cell Surface Receptors in Cancer Biology. A Focus on their Interaction with PDZ Domain Proteins.

Authors:  Bill Cheng; Marine Montmasson; Laurent Terradot; Patricia Rousselle
Journal:  Front Pharmacol       Date:  2016-02-02       Impact factor: 5.810

8.  Evaluation of E-cadherin Expression in Gastric Cancer and Its Correlation with Clinicopathologic Parameters.

Authors:  Zhila Torabizadeh; Anahita Nosrati; Seyedeh Neda Sajadi Saravi; Jamshid Yazdani Charati; Ghasem Janbabai
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

9.  The role of E-cadherin expression in the treatment of western undifferentiated early gastric cancer: Can a biological factor predict lymph node metastasis?

Authors:  Gaetano Piccolo; Antonio Zanghì; Maria Di Vita; Pietro Bisagni; Francesca Lecchi; Andrea Cavallaro; Francesco Cardì; Emanuele Lo Menzo; Alessandro Cappellani
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

Review 10.  Syndecan-1 (CD138), Carcinomas and EMT.

Authors:  John R Couchman
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.